US 7118747
AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents
granted A61KA61K38/05A61K38/06
Quick answer
US patent 7118747 (AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents) held by Pacific Northwest Biotechnology Inc. expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pacific Northwest Biotechnology Inc.
- Grant date
- Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/05, A61K38/06, A61K38/07, A61K38/08